Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_assertion type Assertion NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_head.
- NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_assertion description "[Pharmacological inhibition of the IL-1?, c-Jun N-terminal kinase, MCP-1, or matrix metalloprotease-2 signaling via spinal administration has been shown to attenuate inflammatory, neuropathic, or cancer pain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_provenance.
- NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_assertion evidence source_evidence_literature NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_provenance.
- NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_assertion SIO_000772 20880510 NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_provenance.
- NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_assertion wasDerivedFrom befree-20150227 NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_provenance.
- NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_assertion wasGeneratedBy ECO_0000203 NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_provenance.